BIIB vs FICO · P/E 21, rev $9.89B vs P/E 81, rev $1.99B
Biogen Inc (BIIB) versus Fair Isaac Corporation (FICO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Fair Isaac Corporation (FICO) is a software - application company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported FICO revenue for 2025-09-30 was $1.99B. Net income was $651.9M. FICO currently screens at market cap $45.51B and trailing P/E 80.6.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. FICO currently screens at market cap $45.51B and trailing P/E 80.6.
Not investment advice. Open the BIIB and FICO stock pages for the full models.
Not investment advice.